MarketPulse
E

$ENSC

2 articles found
1 positive
0 negative
1 neutral
BenzingaBenzinga··Vandana Singh

Ensysce Biosciences Stock Jumps on Strategic Review Announcement

Ensysce Biosciences stock surges 58.66% after announcing a strategic review of partnerships, licensing, and asset sales to maximize shareholder value.
ENSCEnsysce Biosciencesstrategic review
GlobeNewswire Inc.GlobeNewswire Inc.··24/7 Market News

Corporate Strategy Shifts to Execution as Companies Advance AI Partnerships and Production Goals

Companies are transitioning from strategy to execution, with Kraig Biocraft starting spider silk production, Rackspace and Palantir partnering on AI deployment, and Ensysce reviewing strategic options.
ENSCKBLBRXTPLTRbiotechoperational execution